How is Asia-like artemisinin resistance emerging in Africa?, Pg2

Key Highlights:

• A new study reveals the emergence of artemisinin resistance in Africa, mirroring early warning signs previously observed in Southeast Asia.
• Kelch13 gene mutations, associated with artemisinin resistance, are increasingly prevalent in Northeast Africa, particularly in Rwanda, Uganda, Tanzania, Eritrea, Sudan, and Ethiopia.
• The study analyzed 1.1 lakh malaria parasite samples from 73 countries over 43 years, identifying 492 unique mutations in the kelch13 gene.
• Researchers emphasize the urgent need for improved genetic surveillance, data sharing, and monitoring of resistance to partner drugs in Africa.
• A decline in malaria samples post-2019 due to the COVID-19 pandemic has created gaps in data, requiring cautious interpretation of findings.

Detailed Insights:

• Artemisinin, derived from the Artemisia annua plant, became a crucial antimalarial drug after its discovery in China during Project 523, led by Tu Youyou.
• Artemisinin-based combination therapies (ACTs) have been the cornerstone of global antimalarial efforts, but resistance has emerged due to widespread use and genetic mutations in the malaria parasite.
• The kelch13 mutations enable the parasite to enter a slow-growing survival mode, reducing the effectiveness of artemisinin.
• Unlike Southeast Asia, where resistance spread through imported mutations, the African mutations appear to be arising independently, posing a unique challenge.
• Factors such as lack of treatment adherence, single-drug usage, and weak surveillance can accelerate the development of artemisinin resistance.
• Diversifying drug use, improving surveillance, and adapting treatment strategies are crucial to prevent a widespread resistance crisis in Africa.
• Reduced malaria funding and disruptions in sample collection due to the COVID-19 pandemic have created data gaps, complicating resistance monitoring efforts.

Scientific/Technical Concepts Involved:

• Artemisinin: A potent antimalarial drug derived from the Artemisia annua plant, effective against chloroquine-resistant strains of malaria.
• Plasmodium falciparum: The most dangerous species of malaria parasite, responsible for the majority of malaria-related deaths globally.
• Kelch13: A gene in the malaria parasite; mutations in this gene are strongly associated with artemisinin resistance.
• Genetic Surveillance: Continuous monitoring of the genetic makeup of pathogens to detect drug resistance and track its spread.